• <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
      <b id="1ykh9"><small id="1ykh9"></small></b>
    1. <b id="1ykh9"></b>

      1. <button id="1ykh9"></button>
        <video id="1ykh9"></video>
      2. west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "Control" 47 results
        • Efficacy and Safety of Intravenous Calcium Infusion for Preventing Ovarian Hyperstimulation Syndrome: A Meta-analysis

          ObjectiveTo systematically review the efficacy and safety of intravenous calcium infusion for preventing ovarian hyperstimulation syndrome (OHSS). MethodsDatabases including PubMed, EMbase, The Cochrane Library (Issue 7, 2015), CNKI, Sinomed and WanFang Data were searched from inception to July 2015 to collect randomized controlled trials (RCTs) and non-RCTs about intravenous calcium infusion for OHSS. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then, meta-analysis was performed using RevMan 5.3 software. ResultsA total of six studies involving 1 061 women were included. The results of meta-analysis showed that intravenous calcium infusion could reduce the incidence of moderate OHSS (RR=0.27, 95% CI 0.11 to 0.65, P=0.003), but not the incidence of severe OHSS (RR=0.77, 95% CI 0.23 to 2.63, P=0.68). In addition, intravenous calcium infusion had a tendency to increase the pregnant rate (RR=1.19, 95% CI 0.94 to 1.50, P=0.15). The subgroup analysis showed that, compared with placebo/no treatment, intravenous calcium infusion reduced the incidence of moderate OHSS, but not the incidence of severe OHSS. There were no statistical differences between intravenous calcium infusion and other positive control (cabergoline and hydroxyethyl starch) in the incidence of OHSS and pregnant rate. No side effect was reported in the studies included. ConclusionsCurrent evidence indicates that intravenous calcium infusion can reduce the incidence of OHSS without influence pregnant outcomes. Due to the quantity and quality limitations of included studies, more high quality case-control or cohort studies are needed to verify the above conclusions.

          Release date: Export PDF Favorites Scan
        • Clinical Application of Two-Port Laparoscopic Cholecystectomy

          Objective To discuss the safety,feasibility,and advantages of two-port laparoscopic cholecystectomy (LC).Methods The clinical data of 114 patients underwent LC from June 2008 to October 2010 were retrospectively analyzed,of which 46 underwent two-port LC (two-port LC group,n=46) and 68 underwent three-port LC (three-port LC group,n=68). The operation time,intraoperative blood loss,postoperative feeding time,postoperative pain,postoperative hospital stay,and hospitalization expenses were compared between two groups. Results All the operations were successful,no postoperative complications occurred in both groups.The operation time in the two-port LC group was longer than that in the three-port LC group (P<0.05). The intraoperative blood loss,postoperative feeding time,postoperative pain,and postoperative hospital stay had no significant differences in two groups (P>0.05). The hospitalization expenses in the two-port group was less than that in the three-port group(P<0.05). Conclusions Two-port LC is a safe and feasible operation in the simple gallstone patients. It is cautious in those patients with acute cholecystitis because of the restricted vision and operation.

          Release date:2016-09-08 10:36 Export PDF Favorites Scan
        • Efficacy and Safety of Early Oxygen Therapy for Acute Myocardial Infarction: A Meta-analysis

          ObjectiveTo systematically review the efficacy and safety of early oxygen therapy for patients with acute myocardial infarction (AMI). MethodsWe searched databases including PubMed, EMbase, The Cochrane Library (Issue 11, 2015) and CBM from inception to October 2015, to collect randomized controlled trials (RCTs) about early oxygen therapy for patients with AMI. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then, meta-analysis was performed by using RevMan 5.3 software. ResultsA total of 7 RCTs involving 1 388 patients were included. The results of meta-analysis showed that, there were no significant differences between the oxygen therapy group and the control group in mortality (OR=1.12, 95%CI 0.57 to 2.20, P=0.75), the incidence of major cardiovascular and cerebrovascular events (MACCE) (OR=1.00, 95%CI 0.46 to 2.18, P=1.00), the incidence of arrhythmia (OR=1.01, 95%CI 0.45 to 2.24, P=0.98) and the incidence of cardiac death (OR=0.53, 95%CI 0.17 to 1.67, P=0.28). But, the oxygen therapy group had higher risk of recurrent myocardial infarction (OR=5.50, 95%CI 1.44 to 20.99, P=0.01) and longer average hospital length of stay (MD=1.28, 95%CI 1.10 to 1.47, P<0.0001). ConclusionThe efficacy of early oxygen therapy for patients with AMI is not clear, even may increase the risk of recurrent myocardial infarction and the average hospital length of stay. Due to the limited quantity and quality of include studies, more high quality studies are needed to verify the above conclusion.

          Release date: Export PDF Favorites Scan
        • Application of Controlled Hypotension in 3 cm Single-port Video-assisted Thoracoscopic Surgery for Lymphadenectomy in Lung Resection

          ObjectiveTo investigate the feasibility and clinical effect of controlled hypotension in 3 cm single-port video-assisted thoracoscopic surgery (VATS) for the lymph node group 7 dissection in the left lung resection. MethodsWe retrospectively analyzed the clinical data of 37 patients with lung cancer who underwent 3 cm single-port VATS from May 2015 to August 2015 in Tongji Hospital, and systolic blood pressure of 12 patients (7 males, 5 females, average age of 58.3 years, range 42-69 years) was controlled between 80-90 mm Hg by nitroglycerin or sodium nitroprusside while the pressure of 25 patients (14 males, 11 females, average age of 57.7 years, range 43-68 years) was not controlled when receiving lymph node group 7 dissection. ResultsControlled hypotension in lymphadenectomy achieved satisfactory results. The lymphadenectomy time of 12 patients with controlled hypotension (18.5±4.3 min on average, range 15.6-25.3 min) was shorter than that of 25 patients without controlled hypotension (24.3±5.1 min on average, range 18.2-29.8 min); the difference was statistically significant (P<0.05). ConclusionControlled hypotension is a simple and feasible method that increases the operating space, and reduces the difficulty of cleaning lymph nodes and the risk of bleeding.

          Release date:2016-12-06 05:27 Export PDF Favorites Scan
        • Hospital Infection Prevention and Control in the Physical Examination Center of A Newly Opened Hospital

          ObjectiveTo analyze the risk factors for hospital infection in the medical physical examination center of a newly opened hospital, and to explore its prevention and control measures. MethodsBetween April and December 2012, we analyzed the risk factors for hospital infection in the physical examination center of a new hospital. A series of hospital infection prevention and control measures such as carrying out education and training of medical personnel, strengthening the prevention of needle stick injuries, implementing strict disinfection and sterilization, improving environmental hygiene, and implementing medical waste management, were developed. ResultsMedical staff's knowledge of disinfection and sterilization was improved; hand hygiene compliance was increased; hospital environmental hygiene was promoted, and medical waste was properly sorted out. ConclusionTaking reasonable measures for infection prevention and control can increase medical staff's awareness of hospital infection prevention and control, improve their practices of infection control and prevent hospital infections from occurring eventually.

          Release date: Export PDF Favorites Scan
        • Design of a benchmark pump model and optimization of hemolysis testing protocol for evaluation of blood pump hemocompatibility

          In vitro hemolysis testing for blood pumps currently faces several challenges, including randomness in control group selection, and numerous sources of uncertainty in the testing methods. These issues lead to high uncertainty, insufficient result credibility, and limited comparability, which hinders the effective evaluation of blood damage induced by blood pumps. This study aims to address these limitations by developing a magnetically-levitated blood pump benchmark model and optimizing the hemolysis testing protocol to reduce result uncertainty. A magnetic bearing was utilized to minimize blood damage, and the injection molding was employed to enhance the machining precision of the pump. The experimental procedures, including blood collection, test loop setup, and the testing process, were optimized to effectively control experimental uncertainty. The results showed that the performance curve of the benchmark pump model was flat, and the coefficient of variation for the hydraulic experimental results was less than 5%. The secondary flow path exhibited good blood washout with no thrombus formation. Under low-flow condition, the average normalized index of hemolysis (NIH) was 0.014 g/100L, with a coefficient of variation of 19.50%. Under high-flow condition, the average NIH was 0.045 g/100L, with a coefficient of variation of 16.45%. The hemolysis values under both conditions were lower than the Abbott CentriMag. In conclusion, we designed a benchmark blood pump model with excellent hemocompatibility and optimized hemolysis testing protocol, which led to low uncertainty in experimental results. The benchmark and optimized hemolysis protocol help to improve the credibility and comparability of in vitro hemolysis testing data, providing a reliable solution for both the industry and regulatory agencies to assess hemocompatibility.

          Release date:2026-02-06 02:05 Export PDF Favorites Scan
        • The Image Quality Analysis and Control of Whole Body Tumor Imaging with 18F-uorodeoxyglucose Positron Emission Tomography/Computer Tomography

          ObjectiveTo analyze the influencing factors for image quality of 18F-deoxyglucose (FDG) positron emission tomography (PET)/CT systemic tumor imaging and explore the method of control in order to improve the PET/CT image quality. MethodsRetrospective analysis of image data from March to June 2011 collected from 1 000 18F-FDG whole body tumor imaging patients was carried out. We separated standard films from non-standard films according to PET/CT image quality criteria. Related factors for non-standard films were analyzed to explore the entire process quality control. ResultsThere were 158 cases of standard films (15.80%), and 842 of non-standard films (84.20%). Artifact was a major factor for non-standard films (93.00%, 783/842) followed by patients’ injection information recording error (2.49%, 21/842), the instrument factor (1.90%, 16/842), incomplete scanning (0.95%, 8/842), muscle and soft tissue uptake (0.83%, 7/842), radionuclide contamination (0.59%, 5/842), and drug injection (0.24%, 2/842). The waste film rate was 5.80% (58/1 000), and the redoing rate was 2.20% (22/1 000). ConclusionComplex and diverse factors affect PET/CT image quality throughout the entire process, but most of them can be controlled if doctors, nurses and technicians coordinate and cooperate with each other. The rigorous routine quality control of equipment and maintenance, patients’ full preparation, appropriate position and scan field, proper parameter settings, and post-processing technology are important factors affecting the image quality.

          Release date: Export PDF Favorites Scan
        • Physicochemical properties of a novel chiral self-assembling peptide R-LIFE-1 and its controlled release to exosomes

          This research aims to investigate the encapsulation and controlled release effect of the newly developed self-assembling peptide R-LIFE-1 on exosomes. The gelling ability and morphological structure of the chiral self-assembling peptide (CSAP) hydrogel were examined using advanced imaging techniques, including atomic force microscopy, transmission electron microscopy, and cryo-scanning electron microscopy. The biocompatibility of the CSAP hydrogel was assessed through optical microscopy and fluorescent staining. Exosomes were isolated via ultrafiltration, and their quality was evaluated using Western blot analysis, nanoparticle tracking analysis, and transmission electron microscopy. The controlled release effect of the CSAP hydrogel on exosomes was quantitatively analyzed using laser confocal microscopy and a BCA assay kit. The results revealed that the self-assembling peptide R-LIFE-1 exhibited spontaneous assembly in the presence of various ions, leading to the formation of nanofibers. These nanofibers were cross-linked, giving rise to a robust nanofiber network structure, which further underwent cross-linking to generate a laminated membrane structure. The nanofibers possessed a large surface area, allowing them to encapsulate a substantial number of water molecules, thereby forming a hydrogel material with high water content. This hydrogel served as a stable spatial scaffold and loading matrix for the three-dimensional culture of cells, as well as the encapsulation and controlled release of exosomes. Importantly, R-LIFE-1 demonstrated excellent biocompatibility, preserving the growth of cells and the biological activity of exosomes. It rapidly formed a three-dimensional network scaffold, enabling the stable loading of cells and exosomes, while exhibiting favorable biocompatibility and reduced cytotoxicity. In conclusion, the findings of this study support the notion that R-LIFE-1 holds significant promise as an ideal tissue engineering material for tissue repair applications.

          Release date: Export PDF Favorites Scan
        • RISKS AND CONTROL OF DISEASES TRANSMISSION IN TRANSPLANTAION OF HUMAN ALLOGENIC BONE

          ObjectiveTo review the risks and control of disease transmission in clinical transplantation of human allogenic bone. MethodsThe related literature on diseases transmission, risks and control, and tissue banking technology in human allogenic bone application was extensively reviewed and analyzed. ResultsThe tissue is not sterilized in transmission cases relative to human allogenic bone transplantation reported abroad. While no transmission case was reported domestically because of final sterilization and strict performance during preparation. ConclusionStrict standard operation, virus inactivation, and final sterilization could effectively control the risks of diseases transmission in human allogenic bone transplantation.

          Release date: Export PDF Favorites Scan
        • Efficacy and safety of controlled hypotension for total hip or knee replacement: a meta-analysis

          ObjectivesTo systematically review the efficacy and safety of controlled hypotension for total hip or knee replacement.MethodsPubMed, EMbase, The Cochrane Library, CNKI, WanFang Data and CBM databases were electronically searched to collect randomized controlled trials (RCTs) on controlled hypotension for total hip or knee replacement from inception to September 2019. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies, then, meta-analysis was performed by RevMan 5.3 software.ResultsA total of 15 RCTs involving 854 patients were included. The results of meta-analysis showed that compared with no controlled hypotension during surgery, controlled hypotension could reduce intraoperative blood loss (MD=?267.35, 95%CI ?314.54 to ?220.16, P<0.000 01), allogeneic blood transfusion (MD=?292.84, 95%CI ?384.95 to ?200.73, P<0.000 01), and 24 h postoperative mini-mental state examination (MMSE) score (MD=?1.08, 95%CI ?1.82 to ?0.34, P=0.004). However, there were no significant differences in 96 h postoperative MMSE score (MD=?0.11, 95%CI ?0.50 to 0.28, P= 0.57) and intraoperative urine volume (MD=57.93, 95%CI ?152.57 to 268.44, P=0.59).ConclusionsThe current evidence shows that controlled hypotension during total hip or knee replacement can reduce intraoperative blood loss and allogeneic blood transfusion. Furthermore, there is no obvious effect on the maintenance of blood perfusion in important organs, despite certain effects on the postoperative cognitive function, which can be recovered in short term. Due to limited quality and quantity of the included studies, more high quality studies are required to verify above conclusions.

          Release date:2021-02-05 02:57 Export PDF Favorites Scan
        5 pages Previous 1 2 3 4 5 Next

        Format

        Content

      3. <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
          <b id="1ykh9"><small id="1ykh9"></small></b>
        1. <b id="1ykh9"></b>

          1. <button id="1ykh9"></button>
            <video id="1ykh9"></video>
          2. 射丝袜